Could this Healthcare Stock really climb 364.82% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Biden's Puppet Master... REVEALED]( you ever suspected that Joe Biden’s not really running America… And that there’s someone else pulling the strings… You’re right! [Click here to see his identity… and discover how he’s about to destroy your way of life]( --------------------------------------------------------------- March 24, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Disturbing Truth About Biden's New Program To Seize Your Cash]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [BioNTech SE]( Symbol: [BNTX]( Recent Price: $129.39 Average Analyst Price Target: $188.67 (45.81%) Market Cap: $32.44B Last Year's EPS: $12.18 Consensus EPS Forecast: $8.84 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Robert Burns, analyst at H.C. Wainwright, reiterates coverage on [BioNTech SE (BNTX)]( in the Healthcare sector with a Buy rating and a price target of $210.00 (20 hours ago). [TipRanks.com]( also reports that [BioNTech SE]( currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $188.67. The target pricing ranges from a high forecast of $300.00 down to a low forecast of $122.00. [BioNTech SE (BNTX)](’s last closing price was $129.39 which would put the average price target at 45.81% upside. Here are 3rd party ratings for [BNTX](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Top 38% (94 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Forever Battery: Making Gas Guzzlers Obsolete]( 2% of cars sold in the U.S. today are electric vehicles… but that’s about to change — FAST. A new battery breakthrough is ready to hit the market. It could revolutionize the $2 trillion automotive industry … and could soon make gas guzzlers obsolete. This technology is predicted to cause a 1,500% surge in electric vehicle sales over the next four years. The company pioneering this new battery could be the investment of a lifetime. [Click here for details.]( --------------------------------------------------------------- [PVH]( Symbol: [PVH]( Recent Price: $73.86 Average Analyst Price Target: $94.13 (27.44%) Market Cap: $4.66B Last Year's EPS: $2.84 Consensus EPS Forecast: $1.67 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Dana Telsey, analyst at Telsey Advisory, reiterates coverage on [PVH (PVH)]( in the Consumer Goods sector with a Buy rating and a price target of $90.00 (2 days ago). [TipRanks.com]( also reports that [PVH]( currently has 8 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $94.13. The target pricing ranges from a high forecast of $110.00 down to a low forecast of $74.00. [PVH (PVH)](’s last closing price was $73.86 which would put the average price target at 27.44% upside. Here are 3rd party ratings for [PVH](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Bottom 28% (179 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Acumen Pharmaceuticals]( Symbol: [ABOS]( Recent Price: $3.98 Average Analyst Price Target: $18.50 (364.82%) Market Cap: $166.98M Last Year's EPS: -$0.16 Consensus EPS Forecast: -$0.28 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Thomas Shrader, analyst at BTIG, reiterates coverage on [Acumen Pharmaceuticals (ABOS)]( in the Healthcare sector with a Buy rating and a price target of $22.00 (1 month ago). [TipRanks.com]( also reports that [Acumen Pharmaceuticals]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $18.50. The target pricing ranges from a high forecast of $22.00 down to a low forecast of $15.00. [Acumen Pharmaceuticals (ABOS)](’s last closing price was $3.98 which would put the average price target at 364.82% upside. Here are 3rd party ratings for [ABOS](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 38% (94 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Forget Tesla... Apple Car May Be The #1 EV Play]( Valley insider, Luke Lango, says his contacts are going crazy over Apple's latest project. Apple is preparing to upend the auto industry with their own EV... and this $5 stock could soar 40X once it goes live! [Click here to learn more.]( --------------------------------------------------------------- [Disc Medicine]( Symbol: [IRON]( Recent Price: $22.84 Average Analyst Price Target: $35.33 (54.68%) Market Cap: $366.05M Last Year's EPS: -$4.1 Consensus EPS Forecast: -$0.85 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Evan Seigerman, analyst at BMO Capital, reiterates coverage on [Disc Medicine (IRON)]( in the Healthcare sector with a Buy rating and a price target of $40.00 (20 hours ago). [TipRanks.com]( also reports that [Disc Medicine]( currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $35.33. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $30.00. [Disc Medicine (IRON)](’s last closing price was $22.84 which would put the average price target at 54.68% upside. Here are 3rd party ratings for [IRON](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 38% (94 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [CytomX Therapeutics]( Symbol: [CTMX]( Recent Price: $1.69 Average Analyst Price Target: $3.15 (86.39%) Market Cap: $114.99M Last Year's EPS: -$0.39 Consensus EPS Forecast: -$0.24 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Mara Goldstein, analyst at Mizuho Securities, reiterates coverage on [CytomX Therapeutics (CTMX)]( in the Healthcare sector with a Hold rating and a price target of $4.00 (3 weeks ago). [TipRanks.com]( also reports that [CytomX Therapeutics]( currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $3.15. The target pricing ranges from a high forecast of $4.00 down to a low forecast of $2.25. [CytomX Therapeutics (CTMX)](’s last closing price was $1.69 which would put the average price target at 86.39% upside. Here are 3rd party ratings for [CTMX](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 38% (94 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Gatos Silver]( Symbol: [GATO]( Recent Price: $4.7 Average Analyst Price Target: $4.75 (1.06%) Market Cap: $320.22M Last Year's EPS: $0.13 Consensus EPS Forecast: $0.14 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Michael Fairbairn, analyst at Canaccord Genuity, reiterates coverage on [Gatos Silver (GATO)]( in the Basic Materials sector with a Hold rating and a price target of $5.00 (2 months ago). [TipRanks.com]( also reports that [Gatos Silver]( currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $4.75. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $4.50. [Gatos Silver (GATO)](’s last closing price was $4.7 which would put the average price target at 1.06% upside. Here are 3rd party ratings for [GATO](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Huazhu Group]( Symbol: [HTHT]( Recent Price: $49.09 Average Analyst Price Target: $58.40 (18.97%) Market Cap: $15.62B Last Year's EPS: -$1.47 Consensus EPS Forecast: $0.1 Expected Earnings Date: Mar 27 2023 Recent Analyst Action: Praveen Choudhary, analyst at Morgan Stanley, reiterates coverage on [Huazhu Group (HTHT)]( in the Services sector with a Buy rating and a price target of $60.00 (20 hours ago). [TipRanks.com]( also reports that [Huazhu Group]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $58.40. The target pricing ranges from a high forecast of $60.00 down to a low forecast of $57.20. [Huazhu Group (HTHT)](’s last closing price was $49.09 which would put the average price target at 18.97% upside. Here are 3rd party ratings for [HTHT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (57 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Warning: Insiders are going all in on these stocks]( €™s the #1 rule of investing? Follow the money. In other words… Where are the insiders putting their cash? Well guys, I followed the money… And it led me to a little ragtag group of stocks you wouldn’t even know exists. [See what I discovered inside this free report.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software